Liju Zong

8PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 21, 2023
Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas.

Liju Zong, Shengwei Mo, Zezheng Sun

|Mar 23, 2022
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study.

Shuangni Yu, Zezheng Sun, Liju Zong

|Dec 01, 2021
Expression of B7 family checkpoint proteins in cervical cancer.

Liju Zong, Yu Gu, Yuncan Zhou

|Oct 15, 2021
B7-H4 Expression in Precancerous Lesions of the Uterine Cervix.

Qianqian Zhang, Liju Zong, Hui Zhang

|Sep 08, 2021
Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer.

Liju Zong, Shengwei Mo, Zezheng Sun

|Jun 20, 2020
Correction to: Expression of the immune checkpoint VISTA in breast cancer.

Liju Zong, Shengwei Mo, Shuangni Yu

Pageof 2

Frequent Collaborators

6 joint publications

Yang Xiang

6 joint publications

Shuangni Yu

5 joint publications

Jie Chen

1 joint publications

Youzhong Zhang